Key result
Systematic review highlights 9 key research gaps in hypertension management including treatment thresholds and telehealth.
Why the study?
Clinical practice guideline development offers an opportunity to systematically identify research gaps, which this study sought to uncover during the Iranian hypertension guideline update.
What are the research gaps in the diagnosis and treatment of hypertension based on the evidence reviewed for the 2021 Iranian guideline update?
Systematic Review (n=227)
What are the research gaps in the diagnosis and treatment of hypertension based on the evidence reviewed for the 2021 Iranian guideline update?
A systematic review for the 2021 Iranian hypertension guideline update identified nine key research gaps, including treatment thresholds, telehealth, and adherence, to guide future research priorities.
Answers are grounded in this paper and cite their sources.
Highlights urgent research needs in hypertension; leaves open optimal thresholds, telehealth, and adherence strategies.
Background: The development of clinical practice guidelines presents a unique opportunity to identify research gaps systematically. This study aimed to uncover such gaps in the hypertension field while updating the Iranian hypertension guideline. Materials and Methods: This study was conducted as part of the systematic review component of the 2021 Iranian hypertension guideline update. An extensive search of electronic databases was performed to identify evidence relevant to PICO (Population, Interventions, Comparisons, Outcomes) questions. Any topic without evidence with high certainty of effect was considered a knowledge gap. Results: A total of 227 studies were reviewed and appraised. Nine topics, such as non-pharmacological treatment, treatment thresholds, visit and follow-up intervals, laboratory tests, drug immunotherapy, adherence to treatment, complementary medicine, telehealth, COVID-19 were identified as research gaps. Conclusions: The identified research gaps can be examined and prioritized by policymakers in the research field, and actions can be taken to plan for addressing them.
No takes yet. Share an insight, caveat, or question.
Sarrafzadegan et al. (2025) conducted a systematic review in Hypertension (n=227). Systematic review of evidence was evaluated on Identification of research gaps (topics without evidence with high certainty of effect). A systematic review of 227 studies identified nine key research gaps in hypertension management, including non-pharmacological treatment, treatment thresholds, and telehealth.
Synapse has enriched 10 related papers. Consider them for comparative context: